Why the Scentre share price is pushing higher today

The Scentre Group (ASX:SCG) share price is pushing higher on Tuesday after releasing an update on its rental collections…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Scentre Group (ASX: SCG) share price has been a strong performer on Tuesday.

In morning trade the Westfield shopping centre operator's shares are up almost 2.5% to $2.24.

Why is the Scentre share price pushing higher?

Investors have been buying Scentre shares this morning after the release of an update on its rental collections for the month of August.

According to the release, the company was able to collect a total of $183 million of gross rent in August. This represents 86% of monthly gross rental billings, which is another month on month improvement for Scentre.

For example, in June the company collected 80% of gross rental billings and then 82% in July.

This is a major improvement and putting it within sight of its pre-pandemic levels. In both January and February, Scentre was collecting 94% or $200 million of gross rental billings.

Is it safe to buy Scentre shares?

While the trends are certainly improving for Scentre, I'm not in a rush to invest just yet. Especially given speculation that the company could be considering a major equity raising in the near future to reduce its debt load.

However, one broker that remains positive on the company is Morgan Stanley. Even after factoring in the possibility of a $1.8 billion equity raising, the broker has held firm with its overweight rating and $2.70 price target.

This price target represents potential upside of 20% for its shares over the next 12 months. The broker has also pencilled in a 16.4 cents per share distribution in FY 2021, which equates to a very generous 7.3% dividend yield.

Though, not everyone is as positive. Last month Citi retained its sell rating and cut its price target to $1.98. This price target implies potential downside of almost 12% for its shares.

Finally, sitting in the middle is Ord Minnett. Its analysts currently have a hold rating and a $2.20 price target on Scentre's shares.

Time will tell which broker has made the right call, but I would side with Ord Minnett right now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »